Old Api Winddown Ltd. (ARLZQ) SEC Filing 8-K Material Event for the period ending Wednesday, March 6, 2019

Aralez Pharmaceuticals Inc.

CIK: 1660719 Ticker: ARLZQ

View differences made from one to another to evaluate Aralez Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aralez Pharmaceuticals Inc..


Assess how Aralez Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aralez Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ARLZQ
CIK: 1660719
Form Type: 8-K Corporate News
Accession Number: 0001104659-19-013263
Submitted to the SEC: Thu Mar 07 2019 8:00:45 AM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Wednesday, March 6, 2019
Industry: Pharmaceutical Preparations
  1. Change in Assets

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: